Back to search
Perennial Allergic Rhinitis (PAR)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Perennial Allergic Rhinitis (PAR) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Perennial Allergic Rhinitis (PAR) trials you may qualify forThis Phase II Trial is Meant to Evaluate the Efficacy, and Safety of JYB1904 Injection in Patients With Perennial Allergic Rhinitis.
This is a Phase 4 randomized, placebo-controlled, parallel-group, single-center, double-blind study to evaluate the effects of mometasone furoate nasal spray (M…
Allergic rhinitis is a common and recurrent ear, nose and throat (ENT) disease. It is a chronic or seasonal condition affecting 10% to 20% of the world's popula…